Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SHPG | Shire PLC Sponsored ADR | 0.31% | 173.28 | 0.4% | $142.79m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.70% | 177.28 | 2.2% | $125.36m | |
| SAGE | SAGE Therapeutics, Inc. | -0.35% | 167.42 | 9.6% | $116.12m | |
| PRGO | Perrigo Co. Plc | -0.55% | 76.00 | 6.7% | $93.00m | |
| ENDP | Endo International Plc | 0.26% | 11.24 | 8.9% | $75.76m | |
| MNK | Mallinckrodt Plc | 0.99% | 22.04 | 21.1% | $73.47m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 0.43% | 96.09 | 21.8% | $69.04m | |
| ZGNX | Zogenix, Inc. | -1.27% | 58.45 | 11.9% | $67.87m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 0.06% | 148.97 | 6.8% | $63.42m | |
| CTLT | Catalent Inc | 0.46% | 43.38 | 2.6% | $62.40m | |
| SUPN | Supernus Pharmaceuticals, Inc. | -1.10% | 54.10 | 6.3% | $40.45m | |
| MDCO | Medicines Company | 0.60% | 40.00 | 21.8% | $39.33m | |
| PTLA | Portola Pharmaceuticals, Inc. | 0.13% | 40.15 | 7.7% | $37.37m | |
| UTHR | United Therapeutics Corporation | 0.77% | 124.08 | 14.4% | $37.00m | |
| AERI | Aerie Pharmaceuticals, Inc. | 1.02% | 74.35 | 7.9% | $32.20m |
Company Profile
Zogenix, Inc. is a pharmaceutical compan. It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen J. Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.